Cece Jr., Cesar L.
HRN: 24-02-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2023
CEFTAZIDIME 1GM (VIAL)
12/07/2023
12/14/2023
IVT
1g
Q8
Hepatoma
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes